GHRP-6 5mg
Strength: 5 mg
CAS: 87616-84-0
Chemical Formula: C₄₆H₅₆N₁₂O₆
Molecular weight: 873.03 g/mol
Peptide Sequence: His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
Synonyms: GHRP6, Growth Hormone Releasing Peptide-6
Storage: Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
Shelf life: 24 months from the manufacturing date.
GHRP 6 (Growth Hormone Releasing Peptide 6) is a synthetic hexapeptide studied for its interaction with the ghrelin receptor (GHS R1a). In laboratory settings, it is used to explore growth hormone signaling pathways, appetite regulation mechanisms, and metabolic modulation, and to evaluate pulsatile hormone release and peptide–receptor binding dynamics in endocrine and metabolic research models. For laboratory research use only; not for human or veterinary use.
Why Choose Medica Depot
Shop hundreds of medical products with no minimums and free shipping on large orders.
400+ products
No order minimums
Free shipping
Loyalty rewards
Trusted since 2007
Account manager
Verified LOT numbers
INFORMATION
What is GHRP-6 (5mg)?
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide classified under endocrine research peptides, specifically as a growth hormone secretagogue (GHS). It is commonly studied for its interaction with the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor.
In laboratory research, GHRP-6 is used to examine signaling pathways related to growth hormone release, receptor binding, and metabolic regulation. Its defined amino acid sequence and well-characterized receptor activity make it ideal for structured experimental studies in endocrine and metabolic research models.
Product Specifications
- CAS Number: 87616-84-0
- Peptide Sequence: His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂
- Synonyms: GHRP6, Growth Hormone Releasing Peptide-6
- Chemical Formula: C₄₆H₅₆N₁₂O₆
- Molecular Weight: 873.03 g/mol
- Purity: ≥99%
- Packaging Format: 5mg lyophilized vial
- Storage Conditions: Store 2–8 °C (≤–20 °C long-term). RT exposure during transport is acceptable. Protect from light.
- Designation: For Laboratory Research Use Only
Key Characteristics of GHRP-6 (5mg)
- Synthetic hexapeptide with a defined and reproducible structure.
- High purity (≥99%) suitable for controlled laboratory experiments.
- Classified as a growth hormone secretagogue for endocrine pathway research.
- Commonly examined in receptor activation and peptide signaling studies.
- Supplied in lyophilized format for research flexibility.
- Requires low-temperature storage to maintain molecular stability.
- Not intended for diagnostic, therapeutic, or clinical applications.
How GHRP-6 (5mg) Supports Research
GHRP-6 is widely used in laboratory settings to study receptor-mediated signaling in the growth hormone pathway. Interacting with the ghrelin receptor in experimental models, it helps researchers investigate hormone release patterns, receptor binding dynamics, and downstream cellular responses.
Its predictable structure and receptor specificity enable reproducible study designs in endocrine and metabolic research systems.
Research Applications & Usage Information
GHRP-6 (5mg) is commonly utilized in laboratory research involving:
- Growth hormone signaling pathway studies
- Ghrelin receptor activation and binding assays
- Endocrine feedback loop modeling
- Peptide-receptor interaction analysis
- Metabolic regulation research models
- Comparative studies with other growth hormone secretagogues
- In vitro cell-based signaling investigations
This peptide is supplied exclusively for laboratory research and must be used in accordance with institutional safety and compliance guidelines.
Handling and Storage Recommendations
- Store at -20°C
- Protect from direct light exposure
- Keep the vial tightly sealed when not in use
- Avoid repeated freeze–thaw cycles
- Handle using appropriate laboratory protective equipment
- Follow standard laboratory handling procedures
Proper storage and careful handling help preserve peptide integrity and support consistent experimental outcomes.
Research Use Only Notice
This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
References
- Bowers CY, Momany FA, Reynolds GA, Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 1984;114(5):1537-1545. doi:10.1210/endo-114-5-1537
- Howard AD, Feighner SD, Cully DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 1996;273(5277):974-977. doi:10.1126/science.273.5277.974
- Smith RG, Cheng K, Schoen WR, et al. A nonpeptidyl growth hormone secretagogue. Science. 1993;260(5111):1640-1643. doi:10.1126/science.8503002
- De la Peña A, Juárez-Rojas JG, Echecopar-Espejo FH, et al. Growth hormone-releasing peptide 6 (GHRP-6) hydrogel for the treatment of acute kidney injury. Front Pharmacol. 2025;16:12777158. doi:10.3389/fphar.2025.12777158
- Berlanga J, Fernández JI, López E, et al. Growth hormone-releasing peptide 6 enhances the healing process. A preclinical model of cutaneous wound healing. Adv Wound Care (New Rochelle). 2016;5(5):211-221. doi:10.1089/wound.2015.0679
- García-Álvarez N, González-Muniesa P, Serrano-Micó M, et al. Growth hormone-releasing peptide-6 (GHRP-6) prevents doxorubicin-induced dilated cardiomyopathy. Front Pharmacol. 2024;15:1402138. doi:10.3389/fphar.2024.1402138
What is GHRP-6 (5mg)?
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide classified under endocrine research peptides, specifically as a growth hormone secretagogue (GHS). It is commonly studied for its interaction with the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor.
In laboratory research, GHRP-6 is used to examine signaling pathways related to growth hormone release, receptor binding, and metabolic regulation. Its defined amino acid sequence and well-characterized receptor activity make it ideal for structured experimental studies in endocrine and metabolic research models.
Product Specifications
- CAS Number: 87616-84-0
- Peptide Sequence: His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂
- Synonyms: GHRP6, Growth Hormone Releasing Peptide-6
- Chemical Formula: C₄₆H₅₆N₁₂O₆
- Molecular Weight: 873.03 g/mol
- Purity: ≥99%
- Packaging Format: 5mg lyophilized vial
- Storage Conditions: Store 2–8 °C (≤–20 °C long-term). RT exposure during transport is acceptable. Protect from light.
- Designation: For Laboratory Research Use Only
Key Characteristics of GHRP-6 (5mg)
- Synthetic hexapeptide with a defined and reproducible structure.
- High purity (≥99%) suitable for controlled laboratory experiments.
- Classified as a growth hormone secretagogue for endocrine pathway research.
- Commonly examined in receptor activation and peptide signaling studies.
- Supplied in lyophilized format for research flexibility.
- Requires low-temperature storage to maintain molecular stability.
- Not intended for diagnostic, therapeutic, or clinical applications.
How GHRP-6 (5mg) Supports Research
GHRP-6 is widely used in laboratory settings to study receptor-mediated signaling in the growth hormone pathway. Interacting with the ghrelin receptor in experimental models, it helps researchers investigate hormone release patterns, receptor binding dynamics, and downstream cellular responses.
Its predictable structure and receptor specificity enable reproducible study designs in endocrine and metabolic research systems.
Research Applications & Usage Information
GHRP-6 (5mg) is commonly utilized in laboratory research involving:
- Growth hormone signaling pathway studies
- Ghrelin receptor activation and binding assays
- Endocrine feedback loop modeling
- Peptide-receptor interaction analysis
- Metabolic regulation research models
- Comparative studies with other growth hormone secretagogues
- In vitro cell-based signaling investigations
This peptide is supplied exclusively for laboratory research and must be used in accordance with institutional safety and compliance guidelines.
Handling and Storage Recommendations
- Store at -20°C
- Protect from direct light exposure
- Keep the vial tightly sealed when not in use
- Avoid repeated freeze–thaw cycles
- Handle using appropriate laboratory protective equipment
- Follow standard laboratory handling procedures
Proper storage and careful handling help preserve peptide integrity and support consistent experimental outcomes.
Research Use Only Notice
This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
References
- Bowers CY, Momany FA, Reynolds GA, Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 1984;114(5):1537-1545. doi:10.1210/endo-114-5-1537
- Howard AD, Feighner SD, Cully DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 1996;273(5277):974-977. doi:10.1126/science.273.5277.974
- Smith RG, Cheng K, Schoen WR, et al. A nonpeptidyl growth hormone secretagogue. Science. 1993;260(5111):1640-1643. doi:10.1126/science.8503002
- De la Peña A, Juárez-Rojas JG, Echecopar-Espejo FH, et al. Growth hormone-releasing peptide 6 (GHRP-6) hydrogel for the treatment of acute kidney injury. Front Pharmacol. 2025;16:12777158. doi:10.3389/fphar.2025.12777158
- Berlanga J, Fernández JI, López E, et al. Growth hormone-releasing peptide 6 enhances the healing process. A preclinical model of cutaneous wound healing. Adv Wound Care (New Rochelle). 2016;5(5):211-221. doi:10.1089/wound.2015.0679
- García-Álvarez N, González-Muniesa P, Serrano-Micó M, et al. Growth hormone-releasing peptide-6 (GHRP-6) prevents doxorubicin-induced dilated cardiomyopathy. Front Pharmacol. 2024;15:1402138. doi:10.3389/fphar.2024.1402138
Related products
